Constitutional hepatic dysfunction (CHD; Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood; D000745:Anemia, Hemolytic, Congenital / Q000097:blood; D001663:Bilirubin / Q000096:biosynthesis / Q000097:blood*; D005260:Female; D006402:Hematologic Diseases / Q000097:blood; D006506:Hepatitis A / Q000097:blood; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000097:blood* / Q000188:drug therapy; D007938:Leukemia / Q000097:blood; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids; D010634:Phenobarbital / Q000008:administration & dosage; D013154:Spleen / Q000378:metabolism; D013156:Splenectomy; D013997:Time Factors
D009539:Nicotinic Acids; D001663:Bilirubin; D010634:Phenobarbital